The first case describing the deliberate M/A of an anticholinergic medication for its euphoric
effects was published in 1960. Further reports followed in Europe before the M/A potential of …

DEAR SIR, Mental disturbances resulting from the use of anti-cholinergic drugs are widely
recognized and well documented (1). Their potential for abuse, however, is still not widely …

Recognizing and reducing abuse Psychiatrists may not detect an ticholinergic misuse
orabuse forsev era! reasons. Anticholinergics can cause an acute toxic delirium charac …

Abuse of the centrally acting anticholinergic agents is a phenomenon occasionally reported
in the medical literature. Anticholinergics, most often used in psychiatry to treat antipsychotic …

To identify factors associated with anticholinergic abuse in patients taking antipsychotics
and anticholinergics and to document the extent of extrapyramidal side effects in …

The use of methylphenidate among adults diagnosed with attention deficit hyperactivity
disorder (ADHD) has generated some concern. 1 Methylphenidate is considered to be a …

Typical meprobamate withdrawal symptoms may include anxiety, insomnia, vomiting,
tremors, muscle twitching, and ataxia (1). Some patients also demonstrate hallucinations …

Sir: Movement disorders have long been associated with a wide variety of medications and
illicit drugs. Dopaminergic agents are well-known precipitants of various dyskinesias …

To the Editors: We have read with interest the article by Adler et al1 about the long-term
safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder …

I was pleased to read that Allnutt and O'Driscoll now acknowledge that the NSWClinicalRiskAssessmentandManagem…
Training Program can play little or no role in the prevention of homicide in NSW. 1 I also …